{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:05Z","timestamp":1791928865573,"version":"4.3.4"},"reference-count":26,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.1167\/iovs.66.11.27","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:30:37Z","timestamp":1755001837000},"page":"27","source":"Crossref","is-referenced-by-count":0,"title":["Progression of Dark-Adapted Visual Fields Over 3 Years in the Rate of Progression in\n                    <i>USH2A<\/i>\n                    -Related Retinal Degeneration (RUSH2A) Study"],"prefix":"10.1167","volume":"66","author":[{"given":"David G.","family":"Birch","sequence":"first","affiliation":[{"name":"Retina Foundation of the\u00a0Southwest, Dallas, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacque L.","family":"Duncan","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lassana","family":"Samarakoon","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Melia","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Audo","sequence":"additional","affiliation":[{"name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Centre de R\u00e9f\u00e9rence Maladies Rares REFERET and, INSERM-DGOS CIC1423 Paris, France"},{"name":"Sorbonne Universit\u00e9, INSERM, CNRS, Institut de la Vision, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Ayala","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Cheetham","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Durham","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Huckfeldt","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Duke University, Duke Eye Center, Durham, North Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Michaelides","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Pennesi","sequence":"additional","affiliation":[{"name":"Retina Foundation of the\u00a0Southwest, Dallas, Texas, United States"},{"name":"Casey Eye Institute - Oregon Health and Science University, Portland, Oregon, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Stingl","sequence":"additional","affiliation":[{"name":"University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Foundation Fighting Blindness Clinical Consortium Investigator Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","first-page":"130","article-title":"On the inheritance of retinitis pigmentosa, with notes of cases","volume":"19","author":"Usher","year":"1914","journal-title":"R Lond Ophthalmol Hosp Rep"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/WCO.0b013e3283218807","article-title":"Update on Usher syndrome","volume":"22","author":"Saihan","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1136\/bjo-2022-321790","article-title":"Inherited causes of combined vision and hearing loss: clinical features and molecular genetics","volume":"107","author":"Guimaraes","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jmg.2009.075143","article-title":"Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa","volume":"47","author":"McGee","year":"2010","journal-title":"J Med Genet"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"108330","DOI":"10.1016\/j.exer.2020.108330","article-title":"USH2A-retinopathy: From genetics to therapeutics","volume":"201","author":"Toualbi","year":"2020","journal-title":"Exp Eye Res"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ophtha.2016.01.021","article-title":"Visual prognosis in USH2A-associated retinitis pigmentosa is worse for patients with Usher syndrome type IIa than for those with nonsyndromic retinitis pigmentosa","volume":"123","author":"Pierrache","year":"2016","journal-title":"Ophthalmology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2020.05.024","article-title":"Baseline visual field findings in the RUSH2A study: associated factors and correlation with other measures of disease severity","volume":"219","author":"Duncan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"bib8","first-page":"954","article-title":"The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa","volume":"28","author":"Birch","year":"1987","journal-title":"Invest Ophth Vis Sci"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/S0161-6420(86)33522-X","article-title":"Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa","volume":"93","author":"Jacobson","year":"1986","journal-title":"Ophthalmology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.6.4.15","article-title":"Dark-adapted chromatic perimetry for measuring rod visual fields in patients with retinitis pigmentosa","volume":"6","author":"Bennett","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.9.11.9","article-title":"The RUSH2A study: best-corrected visual acuity, full-field electroretinography amplitudes, and full-field stimulus thresholds at baseline","volume":"9","author":"Birch","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.4.2.14","article-title":"VFMA: topographic analysis of sensitivity data from full-field static perimetry","volume":"4","author":"Weleber","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.63.3.17","article-title":"The RUSH2A study: dark-adapted visual fields in patients with retinal degeneration associated with biallelic variants in the USH2A gene","volume":"63","author":"Birch","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.13.10.15","article-title":"Endpoints and design for clinical trials in USH2A- related retinal degeneration: results and recommendations from the RUSH2A Natural History Study","volume":"13","author":"Maguire","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1214\/aos\/1176342503","article-title":"Robust regression: asymptotics, conjectures and Monte Carlo","volume":"1","author":"Huber","year":"1973","journal-title":"Ann Stat"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.xops.2024.100648","article-title":"Visual acuity, full-field stimulus thresholds, and electroretinography for 4 years in the rate of progression of USH2A-related Retinal Degeneration (RUSH2A) Study","volume":"5","author":"Birch","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1167\/iovs.18-24931","article-title":"Progression in X-linked retinitis pigmentosa due to ORF15-RPGR mutations: assessment of localized vision changes over 2 years","volume":"59","author":"Cideciyan","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1167\/iovs.15-17786","article-title":"Docosahexaenoic acid slows visual field progression in X- linked retinitis pigmentosa: ancillary outcomes of the DHAX Trial","volume":"56","author":"Hoffman","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1167\/iovs.07-1505","article-title":"Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene","volume":"49","author":"Herrera","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ajo.2018.06.017","article-title":"Efficacy outcome measures for clinical trials of USH2A caused by the common c.2299delG mutation","volume":"193","author":"Calzetti","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"101115","DOI":"10.1016\/j.preteyeres.2022.101115","article-title":"Therapy with voretigene neparvovec. How to measure success?","volume":"92","author":"Stingl","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/tvst.12.4.17","article-title":"Improved rod sensitivity as assessed by two-color dark-adapted perimetry in patients with RPE65- related retinopathy treated with voretigene neparvovec-rzyl","volume":"12","author":"Ku","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000510888","article-title":"Clinical protocols for the evaluation of rod function","volume":"244","author":"Stingl","year":"2021","journal-title":"Ophthalmologica"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bjophthalmol-2020-318286","article-title":"Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec","volume":"106","author":"Stingl","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.13.2.13","article-title":"Chorioretinal atrophy growth after voretigene neparvovec retinotopically is connected to retinal functional rescue","volume":"13","author":"Stingl","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"bib11","volume-title":"Color science","author":"Wyszecki","year":"1982"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:01Z","timestamp":1791927121000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2810667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.11.27","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}